{"id":1697,"date":"2024-09-06T15:01:02","date_gmt":"2024-09-06T15:01:02","guid":{"rendered":"https:\/\/calebdewey.com\/?p=1697"},"modified":"2024-10-18T20:50:42","modified_gmt":"2024-10-18T20:50:42","slug":"how-many-adults-with-private-health-insurance-could-use-glp-1-drugs","status":"publish","type":"post","link":"https:\/\/calebdewey.com\/index.php\/2024\/09\/06\/how-many-adults-with-private-health-insurance-could-use-glp-1-drugs\/","title":{"rendered":"How Many Adults with Private Health Insurance Could Use GLP-1 Drugs"},"content":{"rendered":"<p>More than two in five (42%) or 57.4 million adults under 65 with private insurance could be eligible under clinical criteria for GLP-1 drugs used to treat people with type 2 diabetes, obesity, or excess weight and weight-related health issues, according to a new KFF analysis. Though only about 3% of adults with employer coverage<span class=\"readmore-ellipsis\">&#8230;<\/span><a href=\"https:\/\/www.kff.org\/health-costs\/issue-brief\/how-many-adults-with-private-health-insurance-could-use-glp-1-drugs\/\" class=\"see-more light-beige no-float inline-readmore\">More<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>More than two in five (42%) or 57.4 million adults under 65 with private insurance could be eligible under clinical criteria for GLP-1 drugs used to treat people with type 2 diabetes, obesity, or excess weight and weight-related health issues, according to a new KFF analysis. Though only about 3% of adults with employer coverage&#8230;More<\/p>\n","protected":false},"author":1,"featured_media":1699,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[12],"tags":[],"_links":{"self":[{"href":"https:\/\/calebdewey.com\/index.php\/wp-json\/wp\/v2\/posts\/1697"}],"collection":[{"href":"https:\/\/calebdewey.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/calebdewey.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/calebdewey.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/calebdewey.com\/index.php\/wp-json\/wp\/v2\/comments?post=1697"}],"version-history":[{"count":1,"href":"https:\/\/calebdewey.com\/index.php\/wp-json\/wp\/v2\/posts\/1697\/revisions"}],"predecessor-version":[{"id":1698,"href":"https:\/\/calebdewey.com\/index.php\/wp-json\/wp\/v2\/posts\/1697\/revisions\/1698"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/calebdewey.com\/index.php\/wp-json\/wp\/v2\/media\/1699"}],"wp:attachment":[{"href":"https:\/\/calebdewey.com\/index.php\/wp-json\/wp\/v2\/media?parent=1697"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/calebdewey.com\/index.php\/wp-json\/wp\/v2\/categories?post=1697"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/calebdewey.com\/index.php\/wp-json\/wp\/v2\/tags?post=1697"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}